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THE POTENTIAL OF ACTIVE COMPOUNDS Polyscias Scutellaria AS INHIBITORS IN CERVICAL CANCER 
WITH VIRTUAL SCREENING APPROACH Cervical cancer is a gynecologic disease that has a high enough 
malignancy that affects women. In cervical cancer, it is known that the overexpression of Bcl-2 protein is 14.3% 
in non-invasive cervical carcinoma and 65.2% in invasive cervical carcinoma. The Bcl-2 protein is an important 
regulator of growth and differentiation pathways. Bcl-2 has anti-apoptotic activity but permeabilization occurs 
through the mitochondrial pathway, triggering the release of cytochrome c, which then interacts with Apaf-1 for 
caspase-9 activation and apoptosis occurs. This study aims to determine the mechanism of inhibition of 
overexpression of Bcl-2 protein by bioactive compounds from the Polyscias scutellaria plant with a virtual 
screening approach through in silico studies. The in silico study was carried out with the stages of tracking 
molecular targets, preparation, optimization, simulation and analysis of docking results. The results of the 
docking analysis showed that the bioactive compounds of the mangkokan plant provided inhibitory activity with 
gibbs energy values of -6.07, -5.18, -5.43 and -6.02, respectively. Thus the bioactive compounds from the 
mangkokan plant have potential as Bcl-2 inhibitors in cervical cancer. 
 




POTENSI SENYAWA AKTIF Polyscias Scutellaria SEBAGAI INHIBITOR KANKER SERVIKS DENGAN 
PENDEKATAN VIRTUAL SCREENING Kanker serviks adalah penyakit ginekologik yang memiliki tingkat 
keganasan yang cukup tinggi yang menyerang wanita. Pada kanker serviks diketahui over ekspresi protein Bcl-2 
sebesar 14,3% pada karsinoma serviks non invasive dan 65,2% pada karsinoma serviks invasive. Protein Bcl-2 
merupakan regulator penting dalam jalur pertumbuhan dan diferensiasi. Bcl-2 memiliki aktivitas anti-apoptosis 
tetapi melalui jalur mitokondria terjadi permeabilisasi sehingga memicu pelepasan sitokrom c, yang kemudian 
berinteraksi dengan Apaf-1 untuk aktivasi kaspase-9 dan terjadi apoptosis. Penelitian ini bertujuan untuk 
mengetahui mekanisme inhibisi ekspresi berlebih dari protein Bcl-2 oleh senyawa bioaktif dari tanaman Polyscias 
scutellaria (mangkokan) dengan pendekatan virtual screening melalui studi in silico. Studi in silico dilakukan 
dengan tahapan penelusuran target molekular, preparasi, optimasi, simulasi dan analisis hasil docking. Hasil 
analisis docking menunjukkan senyawa bioaktif tanaman mangkokan memberikan aktivitas inhibisi dengan nilai 
energi gibbs sebesar -6,07, -5,18, -5,43 dan -6,02 berturut-turut. Dengan demikian senyawa bioaktif dari 
tanaman mangkokan memiliki potensi sebagai inhibitor Bcl-2 pada kanker serviks. 
 






Cancer is a disease involving the 
abnormality in cell growth, including women’s 
reproductive systems such as cervix. Cervical 
cancer is a gynaecological disease is quite 
deadly. The data from Globocan International 
Agency for Research on Cancer (IARC) in 2012 
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reported that cervical cancer is the world’s 
fourth most deadly disease (Ferlay et al.,2015). 
The Riskesdas data from 2013 also stated that 
the cancer prevalence in Indonesia was 1.8 in 
every 1000 women (Riset Kesehatan 
Dasar,2018). In Indonesia, cervical cancer is the 
second highest killer disease among women 
after the breast cancer. The mortality profile 
shows that out of the 92,000 deaths among 
women with cancer, the 14.1% were due to 
cervical cancer(World Health Organization, 
2020). 
In cervical cancer, the overexpression of 
Bcl-2 protein is known to be 14.3% in non-
invasive cervical carcinoma and 65.2% in 
invasive cervical carcinoma (Giarnieri et 
al.,2000). The BCL-2 protein family is an 
important regulator of the intrinsic pro-apoptotic 
and anti-apoptotic pathways. Pro-apoptosis 
includes protein Bax, Bak, and Bim, while anti-
apoptosis consists of Bcl-2, Bcl-XL, Bcl-w, and 
Mcl-1 (Campbel et al.,2018). Bcl-2 has an anti-
apoptosis activity and is expressed in various 
types of cancer, especially cervical cancer (Xu 
et al.,2018). Several studies suggest that the 
anti-apoptotic function of Bcl-2 is present in 
mitochondria as well as the endoplasmic 
reticulum mediated by homeostatic and dynamic 
effects on intracellular Ca2+ (Hirata et al.,2012). 
Mitochondria are the main executor of apoptosis 
associated with Bcl-2 protein, which in turn 
cause permeabilization of the outer membrane 
of the mitochondria. This results in the release 
of cytochrome c, which then interacts with Apaf-
1 that triggers the caspase-9 activation and 
leads to apoptosis (Wang et al.,2014).  The 
interaction of cytotoxic compounds with Bcl-2 
protein occurs mainly in the BH3 domain which 
can cause cell death or apoptosis (Thomas et 
al., 2013).  
Currently, anticancer compounds derived 
from natural products are abundant because of 
their wide chemical diversity, physicochemical 
distribution, and high biological activity in 
inhibiting cancer growth (Newman & Giddings, 
2014) (Fang et al., 2018). The results of the 
study of gallic acid  and their derivatives provide 
an in-silico inhibition of BRAF protein in colon 
cancer (Humaedi et al., 2016). Furthermore, 
curcumin  provide excellent inhibitory effects on 
cervical cancer cells through inhibition of 
telomerase activity, RAS and ERK signalling, 
cyclin D1, Cox-2, iNOS and mitochondrial 
activity (Madden et al.,2009). The study of Bai et 
al, 2015 showed that bioactive flavonoid from 
various natural plants, namely butein, have an 
inhibitory effect on migration, invasion, and 
induction of apoptosis in many cancer cells, 
especially cervical cancer (Bai et al.,2015).  
Mangkokan (Polyscias scutellaria) is 
known as a medicinal plant by the general 
public. The components of stems, leaves, fruits, 
and roots have bioactive compounds that are 
used for the treatment of various diseases. 
Generally it contains a group of substances 
such as flavonoids, aurones, chalcones, 
anthocyanins and anthocyanidins (Kurniawan et 
al., 2020). The virtual screening approach with 
in silico studies is one of the quick and easy 
steps to discover the potential of new 
compounds as anticancer. At this study, we 
identified a natural compound from the 
mangkokan plant (Polyscias scutellaria) which 
has potential as an inhibitor in cervical cancer 
by targeting the protein macromolecule Bcl-2. 
 
MATERIALS AND METHODS 
 
Equipment and Materials 
The equipment used in this study silico 
molecular docking was carried out using an Intel 
core i5-4570 computer with 4 GB of RAM. 
Offline software used is MarvinSketch 15.5.11, 
Chimera 1.10.2, pymol 2.3.3, Rasmol 2.7.5, 
Ligplot 2.1 and Autodock 4.2. The materials 
used were the bioactive compounds of 
Mangkokan Plants (Polyscias scutelaria) and 
macromolecular 
https://www.rcsb.org/structure/4AQ3 with code 
targets 4AQ3 for BCL2. 
 
Methods 
This research was conducted at the 
Computing Laboratory of Binawan University. 
The research process consists of 5 stages as 
follows: arranging the target structure of the 
active compound derived from Polyscias 
scutellaria, researching macromolecular targets 
for molecular docking, preparing ligands and 
receptors, simulating docking between 




The preparation of the target structure of 
the mangkokan plant bioactive compound 
(Polyscias scutellaria) includes searching, 
downloading, optimization and separation of 
non-standard residues. The following steps 
macromolecular target tracking was downloaded 
from the RSCB Web with code 4AQ3 for BCL2. 
The next optimization was done using UCSF 
Chimera. Ligand preparation, namely the 
arrangement of ligands includes making 2D 
structures, changing the structure to 3D, and 
adding hydrogen atoms and Gasteiger energy. 
The next stage was making the Grid File 
Parameter (GPF) file and the Docking 
Paramater File (DPF) macromolecular complex 
with ligands used by Autodock 4.2 software. 
Furthermore, the docking simulation process 
between macromolecules and ligands which is 
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operated using the "commond prompt" program 
produces a file with the formar file * .glg for GPF 
and * .dlg to apply for DPF. The last stage is the 
analysis of the docking simulation results. 
 
RESULTS AND DISCUSSION 
 
The Molecular Characteristics of Test Ligand 
Compounds 
In this study, the identification of bioactive 
compounds of mangkokan plants (Polyscias 




12-en-28-oic acid (Johnson-Ajinwo, O. R., 2017) 
et al., 2020). and comparison ligands (Figure 1) 
were in the form of molecular weight, cLog p, 
the number of hydrogen donors, and the 
number of hydrogen acceptors using the 
Ligandscout software. The results of the 
identification of characteristics are obtained in 
table 1 and will then be used as inhibitor 
compounds in in silico molecular docking 
studies. 
 
Tabel 1. The Characteristics of Test Ligands 



















1 Kaemferol 286 2.46 4 6 
2 Myricetin 318 1.85 6 8 












502 4.13 6 10 
 
 
The ligands used in the in-silico molecular 
docking study against the target protein Bcl-2 
(PDB: 4AQ3; figure 2) used the protein 
database access at 
https://www.rcsb.org/structure/4AQ3 were carried 
out by initial screening that met Lipinski's rules, 
namely molecular weight <500 grams/mol, 
number of hydrogen bonded proton donor 
groups <5, total hydrogen bond proton acceptor 
group <10, logarithmic value of the partition 
coefficient in water and 1-octanol <5 (Tice, 
2001). Ligands that meet these rules are 
considered to have the potential to enter the cell 





















Figure 1. Structural Design of Polyscias scutellaria 
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Figure 2. Structure of Bcl-2 
 
The bioactive compounds from the 
Polyscias scutellaria plant and their derivatives 
used in this study have been selected according 
to the Lipinski rules (Table 1) so that these 
ligands are considered to have high bioavability 
potential for the body. Bioavability refers to the 
ability of a drug to be absorbed and circulated in 
the body (Sathishkumar et al., 2012). 
 
An Analysis and Visualization of Docking 
Simulation Results  
In silico molecular docking studies were 
carried out to evaluate the effect of the ligand on 
Bcl-2 macromolecules. The Gibbs energy 
reflects the energy interactions between the 
ligand-protein complexes and those with the 
lowest energy show the more stable 
interactions. The docking results for bioactive 
compounds of mangkokan plants and 
comparative ligands (anticancer drugs) can be 
seen in Table 2.  
 
Table 2. The Gibbs Energy(kkal/mol), and its 
derivatives 











2 Quercetin -5.18 
3 Myricetin -5.43 
4 Kaemferol -6.02 







The docking data in table 2 shows that the 
mangkokan plant compounds gave varying ΔG 
values. Mangkokan plant compounds have the 
potential for inhibitory activity against cervical 
cancer Bcl-2 protein macromolecules as anti-
proliferation and apoptosis induction with ΔG 
values of -6.07, -5.18, -5.43, -6.02 and -6,40 
kkal/mol respectively. The mangkokan plant 
compound (Polyscias scutellaria) which 
provides the best inhibitory activity against the 
Bcl-2 protein is Polyscias scutellaria. In addition 
to ΔG, another indicator of docking results that 
shows the inhibitor standard between ligand-
protein complexes is the inhibition constant (Ki), 
the number of hydrogen bonds and electrostatic 
energy can be seen in Table 3.  
 
Table 3. Simulation results of docking test ligands 
and comparison ligands at the Androgen receptor 
N
o 















































Inhibition constant is an important aspect 
that must be considered in ligand and receptor 
interactions because it is related to binding 
affinity. A lower affinity value indicates that a 
compound requires less energy to interact with 
the receptor. Thus, a lower binding affinity value 
has a greater potential to be able to interact with 
the target protein (Pangastuti et al., 2016) 
In silico molecular docking studies have a good 
indicator when comparing the Gibbs energy 
value (∆G), inhibition constant, and the number 
of hydrogen interactions as a standard inhibitor. 
Strong complex bonds are formed with a low 
Gibbs energy value (∆G), an inhibition constant 
and a large number of hydrogen interactions. As 
seen in tables 1 and 2, according to the criteria 
of a good inhibitor, 3-β-[O-aG55lpha-
Lrhamnopyranosyl-(1-2)- 
αarabionopyranosyl)oxy]-16- α hydroxyolean-
12-en-28-oic acid(1) and kaempferol with Gibbs 
energy (∆G), inhibition constant, number of 
interactions, and hydrogen electrostatic energy 
for 3-β-[O-aG55lpha-Lrhamnopyranosyl-(1-2)- 
αarabionopyranosyl)oxy]-16- α hydroxyolean-
12-en-28-oic acid and kaempferol in table 3 are 
-6.01 kkal/mol, 35.38, 3, and -0.46 respectively. 
Topotecan compounds as comparison ligands 
provide a strong activity with Gibbs energy (∆G), 
inhibition constant, number of interactions, and 
hydrogen electrostatic energy being 38.80, 0, 
and 0.90.  
Of the four test ligands, the bioactive 
compound 3-β- [O-aG55lpha-
Lrhamnopyranosyl- (1-2) - αarabionopyranosyl) 
oxy] -16- α hydroxyolean-12-en-28-oic acid, has 
better potential as an inhibitor against the target 
protein Bcl-2 in cervical cancer with a value of 
∆G -6.07 kkal/mol, Ki 35.38 μM and electrostatic 
energy of -0.46 whereas compared to the 
comparator ligands the value of ∆G was slightly 
larger, it is likely that this is due to the number of 














































Figures 3. Intercation of Polyscias scutellaria ligands 
and their derivates (1. 3-β-[O-aG55lpha-
Lrhamnopyranosyl-(1-2)- αarabionopyranosyl)oxy]-
16- α hydroxyolean-12-en-28-oic acid, 2. Quarecetin, 
3. Mircyetin, 4. Kaemferol and comaprison ligands (5. 
Topotecan) with Bcl-2 macromolecules 
 
Figure 3 shows that the interaction of the 
ligand with the Bcl-2 macromolecule is bound to 
certain amino acids. Ligand 1 is bound to amino 
acids ASP70, VAL92 and ASN102; ligand 2 is 
bound to the amino acids TYR67 and ASN102; 
ligand 3 is bound to the amino acids ALA59, 
ARG66, TYR67 and ASN102; ligand 4 is bound 
to the amino acids ALA59, ARG66, TYR67 and 
ASN102; and ligand 5 is bound to the amino 
acids TYR67 and ARG105. In this interaction a 
strong enough hydrogen bond is formed with an 
average distance of <3.5Ǻ with the possibility of 
inhibition or apoptosis in cancer cells through 
binding to the BH3 domain. Research 
conducted by Sathiskumar et al (2012) showed 
a strong enough interaction between the ligands 
of (ginsenosides) natural compounds against 
Bcl-2 protein, namely the amino acids TYR67, 
GLU95, ARG142, ARG12, THR137, and 
ASN131. In addition, the natural compounds of 
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the Bcl-2 protein in the amino acids ALA146 and 
ARG143 (Chen et al.,2017). There is a 
correlation, between chalcone and flavonoids 
which are secondary metabolites that have 
potential as anti-cancer properties. Using the 
same macromolecule, namely BCL-2, the 




The results of the virtual screening approach 
through in silico studies have shown that the 
bioactive compounds of mangkokan (Polyscias 




en-28-oic acid is the most potential compound 
as  candidates for cervical cancer drugs. Based 
on three important indicators that ΔG -6.07 
kkal/mol, Ki 35.38 μM and ΣIH -0.46. Virtual 
screening simulated the first step in the 
development of new drug candidate searches. 
Further research needs to be done in vitro to 
determine the potential for inhibition of cervical 
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